Spinal Cord Injury: Regeneration

This feed describes latest advances in spinal cord regeneration research and potential nerve regeneration treatments after spinal cord injuries.

October 26, 2021

Engineering spinal cord repair.

Current Opinion in Biotechnology
Jordan W SquairMark A Anderson
October 23, 2021

The vascularization, innervation and myogenesis of early regenerated tail in Gekko japonicus.

Journal of Molecular Histology
Zhuang LiuYan Liu
October 24, 2021
Open Access

The Restorative Effect of Human Amniotic Fluid Stem Cells on Spinal Cord Injury.

Maryam Lale AtaeiMaryam Pashaiasl
October 24, 2021
Open Access

Experimental Treatments for Oedema in Spinal Cord Injury: A Systematic Review and Meta-Analysis.

Emma Masterman, Zubair Ahmed
October 24, 2021
Open Access

Role of Aldynoglia Cells in Neuroinflammatory and Neuroimmune Responses after Spinal Cord Injury.

Vinnitsa Buzoianu-AnguianoErnesto Doncel-Pérez
October 19, 2021

Isolation and characterization of neural stem cells from fetal canine spinal cord.

Neuroscience Letters
Sarah Ingrid Pinto SantosMatheus Levi Tajra Feitosa
October 19, 2021

Clemastine Enhances Myelination, Delays Axonal Loss and Promotes Functional Recovery in Spinal Cord Injury.

Neurochemical Research
Weihong DuXue Jiang
October 15, 2021
Open Access

Bone Marrow Mesenchymal Stem Cell-Derived Exosome-Educated Macrophages Promote Functional Healing After Spinal Cord Injury.

Frontiers in Cellular Neuroscience
Chengjun LiJianzhong Hu
October 15, 2021

The combination of nanoscaffolds and stem cell transplantation: Paving a promising road for spinal cord injury regeneration.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Xiaokun ChenJun Gao
October 13, 2021

Teriflunomide Promotes Oligodendroglial 8,9-Unsaturated Sterol Accumulation and CNS Remyelination.

Neurology. Neuroimmunology and Neuroinflammation
Elodie MartinBruno Stankoff
October 11, 2021

LBO-EMSC Hydrogel Serves a Dual Function in Spinal Cord Injury Restoration via the PI3K-Akt-mTOR Pathway.

ACS Applied Materials & Interfaces
Qingtong YuXiming Xu

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved